Therefore, the objective of this study was to assess the effect of metformin on the treatment regimen in patients with ALL who exhibited high levels of ABCB1 gene expression and to determine its impact on overall survival. The gene discussed is ABCB1; the disease is acute lymphoblastic leukemia.